Takao Miyabayashi

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Satoshi Watanabe, Junta Tanaka, Takeshi Ota et al. · BMC Cancer · 2011 · 394 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia

Junko Baba, Satoshi Watanabe, Yu Saida et al. · Blood · 2012 · 74 citations · Full text

Life Sciences, Immunology, Oncology +14

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Toshiya Fujisaki, Satoshi Watanabe, Takeshi Ota et al. · Frontiers in Oncology · 2021 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Met-enkephalin-Arg6-Gly7-Leu8 in large-cored vesicles of splanchnic nerve terminals innervating guinea pig adrenal chromaffin cells

Shigeru Kobayashi, Takao Miyabayashi, Takashi Uchida et al. · Neuroscience Letters · 1985 · 21 citations

Life Sciences, Neurobiology, Neuroscience +14

Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study

Kazunari Tateishi, Ryo Ko, Takehito Shukuya et al. · The Oncologist · 2019 · 21 citations · Full text

Medicine, Oncology, Chemotherapy +9